{ "source": "Nasdaq Nordic Company News", "fetcher_build": "2026-08-04-fresh-local-files-v5.0.2", "status": "retrieved", "company": "Isofol Medical", "reports": [ { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-04-fresh-local-files-v5.0.2", "retrieved_at": "2026-08-07T04:28:43Z", "company": "Isofol Medical AB", "title": "Isofol Medical AB (publ) publicerar delårsrapport för januari - mars 2026", "category": "Interimsrapport", "date": "2026-05-19", "language": "sv", "report_type": "interim-report", "fiscal_year": 2026, "quarter": "q1", "period": "2026-q1", "report_key": "2026:q1", "release_url": "https://view.news.eu.nasdaq.com/view?id=b6f9817b15cde8964f1a5dd8453f6d48c&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2026-q1\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2026-q1\\release.txt", "attachments": [ { "label": "20260519_PM_Isofol_Delarsrapport Q1 2026.pdf", "url": "https://attachment.news.eu.nasdaq.com/a9874130edaa21e2b0d871806ae537150", "final_url": "https://attachment.news.eu.nasdaq.com/a9874130edaa21e2b0d871806ae537150", "filename": "20260519_PM_Isofol_Delarsrapport_Q1_2026.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2026-q1\\20260519_PM_Isofol_Delarsrapport_Q1_2026.pdf", "content_type": "application/pdf", "size": 103294, "sha256": "66334dd4ddb6680a83d2f70cacde2629012d8998be5588aaa30cc5c6f4c1d0b2", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2026-q1\\20260519_PM_Isofol_Delarsrapport_Q1_2026.pdf", "filename": "20260519_PM_Isofol_Delarsrapport_Q1_2026.pdf", "extension": ".pdf", "size": 103294, "sha256": "66334dd4ddb6680a83d2f70cacde2629012d8998be5588aaa30cc5c6f4c1d0b2", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2026-q1\\extracted\\20260519_PM_Isofol_Delarsrapport_Q1_2026\\20260519_PM_Isofol_Delarsrapport_Q1_2026.txt", "text_chars": 4614, "metadata": { "page_count": 2, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2026-q1\\extracted\\20260519_PM_Isofol_Delarsrapport_Q1_2026\\20260519_PM_Isofol_Delarsrapport_Q1_2026.extraction.json" } }, { "label": "20260519_Isofol_Delarsrapport Q1 2026.pdf", "url": "https://attachment.news.eu.nasdaq.com/a94a051544e5822f96cb831b364dd2210", "final_url": "https://attachment.news.eu.nasdaq.com/a94a051544e5822f96cb831b364dd2210", "filename": "20260519_Isofol_Delarsrapport_Q1_2026.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2026-q1\\20260519_Isofol_Delarsrapport_Q1_2026.pdf", "content_type": "application/pdf", "size": 4417881, "sha256": "8c49180568c15e5e7877b572a17d0364cab49ba2ad7049d4e7b71a3f1b1d3b10", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2026-q1\\20260519_Isofol_Delarsrapport_Q1_2026.pdf", "filename": "20260519_Isofol_Delarsrapport_Q1_2026.pdf", "extension": ".pdf", "size": 4417881, "sha256": "8c49180568c15e5e7877b572a17d0364cab49ba2ad7049d4e7b71a3f1b1d3b10", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2026-q1\\extracted\\20260519_Isofol_Delarsrapport_Q1_2026\\20260519_Isofol_Delarsrapport_Q1_2026.txt", "text_chars": 32659, "metadata": { "page_count": 15, "empty_pages": 0, "encrypted": true }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2026-q1\\extracted\\20260519_Isofol_Delarsrapport_Q1_2026\\20260519_Isofol_Delarsrapport_Q1_2026.extraction.json" } } ], "announcement_id": "1442818", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-04-fresh-local-files-v5.0.2", "retrieved_at": "2026-08-07T04:28:52Z", "company": "Isofol Medical AB", "title": "Isofol Medical AB (publ) offentliggör årsredovisning och bolagsstyrningsrapport för 2025", "category": "Bokslut och Verksamhetsberättelse", "date": "2026-04-10", "language": "sv", "report_type": "annual-report", "fiscal_year": 2025, "quarter": "annual", "period": "2025-annual", "report_key": "2025:annual", "release_url": "https://view.news.eu.nasdaq.com/view?id=b98dbde6b06b5d0efdc8c3d81d7a88e80&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2025-annual\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2025-annual\\release.txt", "attachments": [ { "label": "Isofol_Arsredovisning 2025.pdf", "url": "https://attachment.news.eu.nasdaq.com/a12d1436b8ef91ab5341635badeada46e", "final_url": "https://attachment.news.eu.nasdaq.com/a12d1436b8ef91ab5341635badeada46e", "filename": "Isofol_Arsredovisning_2025.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2025-annual\\Isofol_Arsredovisning_2025.pdf", "content_type": "application/pdf", "size": 3670292, "sha256": "0351fd620637e1c5f22e2296336fbf47aee355388520cb2602a261753c946c62", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2025-annual\\Isofol_Arsredovisning_2025.pdf", "filename": "Isofol_Arsredovisning_2025.pdf", "extension": ".pdf", "size": 3670292, "sha256": "0351fd620637e1c5f22e2296336fbf47aee355388520cb2602a261753c946c62", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2025-annual\\extracted\\Isofol_Arsredovisning_2025\\Isofol_Arsredovisning_2025.txt", "text_chars": 204995, "metadata": { "page_count": 60, "empty_pages": 1, "encrypted": true }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2025-annual\\extracted\\Isofol_Arsredovisning_2025\\Isofol_Arsredovisning_2025.extraction.json" } }, { "label": "20260410_PM_Isofol_Arsredovisning 2025.pdf", "url": "https://attachment.news.eu.nasdaq.com/a0928f4017d0d4666bf590354659f2e95", "final_url": "https://attachment.news.eu.nasdaq.com/a0928f4017d0d4666bf590354659f2e95", "filename": "20260410_PM_Isofol_Arsredovisning_2025.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2025-annual\\20260410_PM_Isofol_Arsredovisning_2025.pdf", "content_type": "application/pdf", "size": 131521, "sha256": "fcdf71dc0a84b5b405be57e9e5b3e26559d50860b5a784f2a984dde5800a27f9", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2025-annual\\20260410_PM_Isofol_Arsredovisning_2025.pdf", "filename": "20260410_PM_Isofol_Arsredovisning_2025.pdf", "extension": ".pdf", "size": 131521, "sha256": "fcdf71dc0a84b5b405be57e9e5b3e26559d50860b5a784f2a984dde5800a27f9", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2025-annual\\extracted\\20260410_PM_Isofol_Arsredovisning_2025\\20260410_PM_Isofol_Arsredovisning_2025.txt", "text_chars": 2228, "metadata": { "page_count": 1, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2025-annual\\extracted\\20260410_PM_Isofol_Arsredovisning_2025\\20260410_PM_Isofol_Arsredovisning_2025.extraction.json" } } ], "announcement_id": "1433493", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-04-fresh-local-files-v5.0.2", "retrieved_at": "2026-08-07T04:29:02Z", "company": "Isofol Medical AB", "title": "Isofol Medical AB (publ) publicerar bokslutskommuniké för januari - december 2025", "category": "Bokslutskommuniké", "date": "2026-02-18", "language": "sv", "report_type": "year-end-report", "fiscal_year": 2025, "quarter": "q4", "period": "2025-q4", "report_key": "2025:q4", "release_url": "https://view.news.eu.nasdaq.com/view?id=bcb52f5e9484e4437e294fa92a6b4134a&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2025-q4\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2025-q4\\release.txt", "attachments": [ { "label": "20260218_Isofol_Bokslutskommunike 2025.pdf", "url": "https://attachment.news.eu.nasdaq.com/af4cd051abbbf1d79adb663dada035623", "final_url": "https://attachment.news.eu.nasdaq.com/af4cd051abbbf1d79adb663dada035623", "filename": "20260218_Isofol_Bokslutskommunike_2025.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2025-q4\\20260218_Isofol_Bokslutskommunike_2025.pdf", "content_type": "application/pdf", "size": 1269882, "sha256": "40278a6b5ac5a547ff31897a2157db338fbad145ce8cad5e37114abdcf08ef68", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2025-q4\\20260218_Isofol_Bokslutskommunike_2025.pdf", "filename": "20260218_Isofol_Bokslutskommunike_2025.pdf", "extension": ".pdf", "size": 1269882, "sha256": "40278a6b5ac5a547ff31897a2157db338fbad145ce8cad5e37114abdcf08ef68", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2025-q4\\extracted\\20260218_Isofol_Bokslutskommunike_2025\\20260218_Isofol_Bokslutskommunike_2025.txt", "text_chars": 39927, "metadata": { "page_count": 16, "empty_pages": 0, "encrypted": true }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2025-q4\\extracted\\20260218_Isofol_Bokslutskommunike_2025\\20260218_Isofol_Bokslutskommunike_2025.extraction.json" } }, { "label": "20260218_PM_Isofol_Bokslutskommunike 2025.pdf", "url": "https://attachment.news.eu.nasdaq.com/ac9ed972d587e67b9a1fdc66caac20f13", "final_url": "https://attachment.news.eu.nasdaq.com/ac9ed972d587e67b9a1fdc66caac20f13", "filename": "20260218_PM_Isofol_Bokslutskommunike_2025.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2025-q4\\20260218_PM_Isofol_Bokslutskommunike_2025.pdf", "content_type": "application/pdf", "size": 105642, "sha256": "67e676baa70b6e0181e3da553335d3aa0b0d09d1ea6a35bde601d989c8417c94", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2025-q4\\20260218_PM_Isofol_Bokslutskommunike_2025.pdf", "filename": "20260218_PM_Isofol_Bokslutskommunike_2025.pdf", "extension": ".pdf", "size": 105642, "sha256": "67e676baa70b6e0181e3da553335d3aa0b0d09d1ea6a35bde601d989c8417c94", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2025-q4\\extracted\\20260218_PM_Isofol_Bokslutskommunike_2025\\20260218_PM_Isofol_Bokslutskommunike_2025.txt", "text_chars": 3845, "metadata": { "page_count": 2, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2025-q4\\extracted\\20260218_PM_Isofol_Bokslutskommunike_2025\\20260218_PM_Isofol_Bokslutskommunike_2025.extraction.json" } } ], "announcement_id": "1420862", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-04-fresh-local-files-v5.0.2", "retrieved_at": "2026-08-07T04:29:15Z", "company": "Isofol Medical AB", "title": "Isofol Medical AB (publ) publicerar delårsrapport, januari-september 2025", "category": "Interimsrapport", "date": "2025-11-12", "language": "sv", "report_type": "interim-report", "fiscal_year": 2025, "quarter": "q3", "period": "2025-q3", "report_key": "2025:q3", "release_url": "https://view.news.eu.nasdaq.com/view?id=b10ba296260d1545805e08ae4b5788782&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2025-q3\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2025-q3\\release.txt", "attachments": [ { "label": "20251112_PM_Isofol_Delarsrapport Q3 2025.pdf", "url": "https://attachment.news.eu.nasdaq.com/a60fb91da96ba320dcb38be00b7713690", "final_url": "https://attachment.news.eu.nasdaq.com/a60fb91da96ba320dcb38be00b7713690", "filename": "20251112_PM_Isofol_Delarsrapport_Q3_2025.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2025-q3\\20251112_PM_Isofol_Delarsrapport_Q3_2025.pdf", "content_type": "application/pdf", "size": 111133, "sha256": "ad3692b57fd2bbc09daee53851dec1082bf3d7bb646149495c0db82ccd8c64e6", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2025-q3\\20251112_PM_Isofol_Delarsrapport_Q3_2025.pdf", "filename": "20251112_PM_Isofol_Delarsrapport_Q3_2025.pdf", "extension": ".pdf", "size": 111133, "sha256": "ad3692b57fd2bbc09daee53851dec1082bf3d7bb646149495c0db82ccd8c64e6", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2025-q3\\extracted\\20251112_PM_Isofol_Delarsrapport_Q3_2025\\20251112_PM_Isofol_Delarsrapport_Q3_2025.txt", "text_chars": 4497, "metadata": { "page_count": 2, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2025-q3\\extracted\\20251112_PM_Isofol_Delarsrapport_Q3_2025\\20251112_PM_Isofol_Delarsrapport_Q3_2025.extraction.json" } }, { "label": "20251112_Isofol_Delarsrapport Q3 2025.pdf", "url": "https://attachment.news.eu.nasdaq.com/a627cf23052d77b8a20661a77b753e194", "final_url": "https://attachment.news.eu.nasdaq.com/a627cf23052d77b8a20661a77b753e194", "filename": "20251112_Isofol_Delarsrapport_Q3_2025.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2025-q3\\20251112_Isofol_Delarsrapport_Q3_2025.pdf", "content_type": "application/pdf", "size": 12522388, "sha256": "7f28877a00d64ee1f5f48a195642bc8f59665c7b40e20049568be9d0f87c1a45", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2025-q3\\20251112_Isofol_Delarsrapport_Q3_2025.pdf", "filename": "20251112_Isofol_Delarsrapport_Q3_2025.pdf", "extension": ".pdf", "size": 12522388, "sha256": "7f28877a00d64ee1f5f48a195642bc8f59665c7b40e20049568be9d0f87c1a45", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2025-q3\\extracted\\20251112_Isofol_Delarsrapport_Q3_2025\\20251112_Isofol_Delarsrapport_Q3_2025.txt", "text_chars": 43451, "metadata": { "page_count": 16, "empty_pages": 0, "encrypted": true }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2025-q3\\extracted\\20251112_Isofol_Delarsrapport_Q3_2025\\20251112_Isofol_Delarsrapport_Q3_2025.extraction.json" } } ], "announcement_id": "1400106", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-04-fresh-local-files-v5.0.2", "retrieved_at": "2026-08-07T04:29:23Z", "company": "Isofol Medical AB", "title": "Isofol Medical AB (publ) publicerar delårsrapport, januari-juni 2025", "category": "Halvårsrapport", "date": "2025-08-26", "language": "sv", "report_type": "interim-report", "fiscal_year": 2025, "quarter": "q2", "period": "2025-q2", "report_key": "2025:q2", "release_url": "https://view.news.eu.nasdaq.com/view?id=b1dcd913336ef01255e44309815debcf4&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2025-q2\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2025-q2\\release.txt", "attachments": [ { "label": "20250826_Isofol_Delarsrapport Q2 2025.pdf", "url": "https://attachment.news.eu.nasdaq.com/ab5bbf6f23332371e4710057719a0e648", "final_url": "https://attachment.news.eu.nasdaq.com/ab5bbf6f23332371e4710057719a0e648", "filename": "20250826_Isofol_Delarsrapport_Q2_2025.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2025-q2\\20250826_Isofol_Delarsrapport_Q2_2025.pdf", "content_type": "application/pdf", "size": 7533192, "sha256": "e381dab161da96be93503865cb56f5333a2d89e9eacbdf4de61813bbac6f1da8", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2025-q2\\20250826_Isofol_Delarsrapport_Q2_2025.pdf", "filename": "20250826_Isofol_Delarsrapport_Q2_2025.pdf", "extension": ".pdf", "size": 7533192, "sha256": "e381dab161da96be93503865cb56f5333a2d89e9eacbdf4de61813bbac6f1da8", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2025-q2\\extracted\\20250826_Isofol_Delarsrapport_Q2_2025\\20250826_Isofol_Delarsrapport_Q2_2025.txt", "text_chars": 39006, "metadata": { "page_count": 16, "empty_pages": 0, "encrypted": true }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2025-q2\\extracted\\20250826_Isofol_Delarsrapport_Q2_2025\\20250826_Isofol_Delarsrapport_Q2_2025.extraction.json" } }, { "label": "20250826_PM_Isofol_Delarsrapport Q2 2025.pdf", "url": "https://attachment.news.eu.nasdaq.com/aa62686295e7e2b1f397dfdb8cd70c14d", "final_url": "https://attachment.news.eu.nasdaq.com/aa62686295e7e2b1f397dfdb8cd70c14d", "filename": "20250826_PM_Isofol_Delarsrapport_Q2_2025.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2025-q2\\20250826_PM_Isofol_Delarsrapport_Q2_2025.pdf", "content_type": "application/pdf", "size": 100335, "sha256": "13fe40ed88025df970bd540f6e27f7d3377207818c128bf2d044e4331945a1fe", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2025-q2\\20250826_PM_Isofol_Delarsrapport_Q2_2025.pdf", "filename": "20250826_PM_Isofol_Delarsrapport_Q2_2025.pdf", "extension": ".pdf", "size": 100335, "sha256": "13fe40ed88025df970bd540f6e27f7d3377207818c128bf2d044e4331945a1fe", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2025-q2\\extracted\\20250826_PM_Isofol_Delarsrapport_Q2_2025\\20250826_PM_Isofol_Delarsrapport_Q2_2025.txt", "text_chars": 4780, "metadata": { "page_count": 2, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2025-q2\\extracted\\20250826_PM_Isofol_Delarsrapport_Q2_2025\\20250826_PM_Isofol_Delarsrapport_Q2_2025.extraction.json" } } ], "announcement_id": "1385222", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-04-fresh-local-files-v5.0.2", "retrieved_at": "2026-08-07T04:29:34Z", "company": "Isofol Medical AB", "title": "Isofol Medical AB (publ) publicerar delårsrapport, januari - mars 2025", "category": "Interimsrapport", "date": "2025-05-21", "language": "sv", "report_type": "interim-report", "fiscal_year": 2025, "quarter": "q1", "period": "2025-q1", "report_key": "2025:q1", "release_url": "https://view.news.eu.nasdaq.com/view?id=b72c901e4dcb7192ebe7c920bcbb5b9ac&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2025-q1\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2025-q1\\release.txt", "attachments": [ { "label": "20250521_PM_Isofol Delarsrapport Q1 2025_Final.pdf", "url": "https://attachment.news.eu.nasdaq.com/a84d6ceec9cea6b06c4be1c7c20016ae7", "final_url": "https://attachment.news.eu.nasdaq.com/a84d6ceec9cea6b06c4be1c7c20016ae7", "filename": "20250521_PM_Isofol_Delarsrapport_Q1_2025_Final.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2025-q1\\20250521_PM_Isofol_Delarsrapport_Q1_2025_Final.pdf", "content_type": "application/pdf", "size": 93713, "sha256": "df6d42223699a76df67fd0e473e247a33e1f21aa8393ef83c4020c20000ef6a3", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2025-q1\\20250521_PM_Isofol_Delarsrapport_Q1_2025_Final.pdf", "filename": "20250521_PM_Isofol_Delarsrapport_Q1_2025_Final.pdf", "extension": ".pdf", "size": 93713, "sha256": "df6d42223699a76df67fd0e473e247a33e1f21aa8393ef83c4020c20000ef6a3", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2025-q1\\extracted\\20250521_PM_Isofol_Delarsrapport_Q1_2025_Fina\\20250521_PM_Isofol_Delarsrapport_Q1_2025_Final.txt", "text_chars": 4386, "metadata": { "page_count": 2, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2025-q1\\extracted\\20250521_PM_Isofol_Delarsrapport_Q1_2025_Fina\\20250521_PM_Isofol_Delarsrapport_Q1_2025_Final.extraction.json" } }, { "label": "20250521_Isofol Delarsrapport Q1 2025_final.pdf", "url": "https://attachment.news.eu.nasdaq.com/a4e3094058e35d8dddd58ce6aae6499c3", "final_url": "https://attachment.news.eu.nasdaq.com/a4e3094058e35d8dddd58ce6aae6499c3", "filename": "20250521_Isofol_Delarsrapport_Q1_2025_final.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2025-q1\\20250521_Isofol_Delarsrapport_Q1_2025_final.pdf", "content_type": "application/pdf", "size": 742728, "sha256": "1c80379a14ac40e1ad27d4eaa65eb457479124a8b6dd7d041de5f73f9e41600b", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2025-q1\\20250521_Isofol_Delarsrapport_Q1_2025_final.pdf", "filename": "20250521_Isofol_Delarsrapport_Q1_2025_final.pdf", "extension": ".pdf", "size": 742728, "sha256": "1c80379a14ac40e1ad27d4eaa65eb457479124a8b6dd7d041de5f73f9e41600b", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2025-q1\\extracted\\20250521_Isofol_Delarsrapport_Q1_2025_final\\20250521_Isofol_Delarsrapport_Q1_2025_final.txt", "text_chars": 33965, "metadata": { "page_count": 15, "empty_pages": 0, "encrypted": true }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2025-q1\\extracted\\20250521_Isofol_Delarsrapport_Q1_2025_final\\20250521_Isofol_Delarsrapport_Q1_2025_final.extraction.json" } } ], "announcement_id": "1364601", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-04-fresh-local-files-v5.0.2", "retrieved_at": "2026-08-07T04:29:52Z", "company": "Isofol Medical AB", "title": "Isofol Medical AB (publ) offentliggör årsredovisning och bolagsstyrningsrapport för 2024", "category": "Bokslut och Verksamhetsberättelse", "date": "2025-04-11", "language": "sv", "report_type": "annual-report", "fiscal_year": 2024, "quarter": "annual", "period": "2024-annual", "report_key": "2024:annual", "release_url": "https://view.news.eu.nasdaq.com/view?id=b951c15b6ca77e7887c314196c1fcace6&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2024-annual\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2024-annual\\release.txt", "attachments": [ { "label": "20250411_PM_Isofol_Arsredovisning 2024.pdf", "url": "https://attachment.news.eu.nasdaq.com/ace2d3dbb1fa9905dbaadb1984801d0cf", "final_url": "https://attachment.news.eu.nasdaq.com/ace2d3dbb1fa9905dbaadb1984801d0cf", "filename": "20250411_PM_Isofol_Arsredovisning_2024.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2024-annual\\20250411_PM_Isofol_Arsredovisning_2024.pdf", "content_type": "application/pdf", "size": 61128, "sha256": "fc37bb9635b87b6fa91b30ad56e37c638743ab1bf0c9b572e113aff0581f4be4", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2024-annual\\20250411_PM_Isofol_Arsredovisning_2024.pdf", "filename": "20250411_PM_Isofol_Arsredovisning_2024.pdf", "extension": ".pdf", "size": 61128, "sha256": "fc37bb9635b87b6fa91b30ad56e37c638743ab1bf0c9b572e113aff0581f4be4", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2024-annual\\extracted\\20250411_PM_Isofol_Arsredovisning_2024\\20250411_PM_Isofol_Arsredovisning_2024.txt", "text_chars": 1844, "metadata": { "page_count": 1, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2024-annual\\extracted\\20250411_PM_Isofol_Arsredovisning_2024\\20250411_PM_Isofol_Arsredovisning_2024.extraction.json" } }, { "label": "Isofol_Arsredovisning 2024.pdf", "url": "https://attachment.news.eu.nasdaq.com/aba6d73344c5e9bd4360f6fa6734d66ef", "final_url": "https://attachment.news.eu.nasdaq.com/aba6d73344c5e9bd4360f6fa6734d66ef", "filename": "Isofol_Arsredovisning_2024.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2024-annual\\Isofol_Arsredovisning_2024.pdf", "content_type": "application/pdf", "size": 6327611, "sha256": "f97cd8c3aa77ec1729fac9f7530958ddc93b3fedad93f133d43534becb3e0885", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2024-annual\\Isofol_Arsredovisning_2024.pdf", "filename": "Isofol_Arsredovisning_2024.pdf", "extension": ".pdf", "size": 6327611, "sha256": "f97cd8c3aa77ec1729fac9f7530958ddc93b3fedad93f133d43534becb3e0885", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2024-annual\\extracted\\Isofol_Arsredovisning_2024\\Isofol_Arsredovisning_2024.txt", "text_chars": 201784, "metadata": { "page_count": 60, "empty_pages": 0, "encrypted": true }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2024-annual\\extracted\\Isofol_Arsredovisning_2024\\Isofol_Arsredovisning_2024.extraction.json" } } ], "announcement_id": "1355420", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-04-fresh-local-files-v5.0.2", "retrieved_at": "2026-08-07T04:29:58Z", "company": "Isofol Medical AB", "title": "Isofol Medical AB (publ) publicerar bokslutskommuniké, januari - december 2024", "category": "Bokslutskommuniké", "date": "2025-02-19", "language": "sv", "report_type": "year-end-report", "fiscal_year": 2024, "quarter": "q4", "period": "2024-q4", "report_key": "2024:q4", "release_url": "https://view.news.eu.nasdaq.com/view?id=bb29c95495e537109a294fb7908c5a727&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2024-q4\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2024-q4\\release.txt", "attachments": [ { "label": "20250219_Isofol_Bokslutskommunike 2024.pdf", "url": "https://attachment.news.eu.nasdaq.com/ad98d022eeb2b9b89d9881402e4e933b1", "final_url": "https://attachment.news.eu.nasdaq.com/ad98d022eeb2b9b89d9881402e4e933b1", "filename": "20250219_Isofol_Bokslutskommunike_2024.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2024-q4\\20250219_Isofol_Bokslutskommunike_2024.pdf", "content_type": "application/pdf", "size": 614266, "sha256": "0b823cc1c1e63134b2d5985766e994d3c8cfc52863f8bd33fbc5ebd6559a2024", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2024-q4\\20250219_Isofol_Bokslutskommunike_2024.pdf", "filename": "20250219_Isofol_Bokslutskommunike_2024.pdf", "extension": ".pdf", "size": 614266, "sha256": "0b823cc1c1e63134b2d5985766e994d3c8cfc52863f8bd33fbc5ebd6559a2024", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2024-q4\\extracted\\20250219_Isofol_Bokslutskommunike_2024\\20250219_Isofol_Bokslutskommunike_2024.txt", "text_chars": 39667, "metadata": { "page_count": 16, "empty_pages": 0, "encrypted": true }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2024-q4\\extracted\\20250219_Isofol_Bokslutskommunike_2024\\20250219_Isofol_Bokslutskommunike_2024.extraction.json" } }, { "label": "20250219_PM_Isofol_Bokslutskommunike 2024.pdf", "url": "https://attachment.news.eu.nasdaq.com/a503cd5381ba56f8e192b59eecf106501", "final_url": "https://attachment.news.eu.nasdaq.com/a503cd5381ba56f8e192b59eecf106501", "filename": "20250219_PM_Isofol_Bokslutskommunike_2024.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2024-q4\\20250219_PM_Isofol_Bokslutskommunike_2024.pdf", "content_type": "application/pdf", "size": 96666, "sha256": "2cd05e1cdf91426a6d63772033a44e14e906f84d641e5de6522b72185095fa80", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2024-q4\\20250219_PM_Isofol_Bokslutskommunike_2024.pdf", "filename": "20250219_PM_Isofol_Bokslutskommunike_2024.pdf", "extension": ".pdf", "size": 96666, "sha256": "2cd05e1cdf91426a6d63772033a44e14e906f84d641e5de6522b72185095fa80", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2024-q4\\extracted\\20250219_PM_Isofol_Bokslutskommunike_2024\\20250219_PM_Isofol_Bokslutskommunike_2024.txt", "text_chars": 4867, "metadata": { "page_count": 2, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2024-q4\\extracted\\20250219_PM_Isofol_Bokslutskommunike_2024\\20250219_PM_Isofol_Bokslutskommunike_2024.extraction.json" } } ], "announcement_id": "1343892", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-04-fresh-local-files-v5.0.2", "retrieved_at": "2026-08-07T04:30:08Z", "company": "Isofol Medical AB", "title": "Isofol Medical AB (publ) publicerar delårsrapport, januari-september 2024", "category": "Interimsrapport", "date": "2024-11-12", "language": "sv", "report_type": "interim-report", "fiscal_year": 2024, "quarter": "q3", "period": "2024-q3", "report_key": "2024:q3", "release_url": "https://view.news.eu.nasdaq.com/view?id=b5c2e34493ddf0a17b69df52bdfcb831a&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2024-q3\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2024-q3\\release.txt", "attachments": [ { "label": "20241112_Isofol_Delarsrapport Q3 2024_Final.pdf", "url": "https://attachment.news.eu.nasdaq.com/ad8adca4674ca0d2a4db155a9e8a7a450", "final_url": "https://attachment.news.eu.nasdaq.com/ad8adca4674ca0d2a4db155a9e8a7a450", "filename": "20241112_Isofol_Delarsrapport_Q3_2024_Final.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2024-q3\\20241112_Isofol_Delarsrapport_Q3_2024_Final.pdf", "content_type": "application/pdf", "size": 812812, "sha256": "7a278edff0fc15b3d6137ba72239576aca8730ef77af21e416ce9a318a5c1b45", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2024-q3\\20241112_Isofol_Delarsrapport_Q3_2024_Final.pdf", "filename": "20241112_Isofol_Delarsrapport_Q3_2024_Final.pdf", "extension": ".pdf", "size": 812812, "sha256": "7a278edff0fc15b3d6137ba72239576aca8730ef77af21e416ce9a318a5c1b45", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2024-q3\\extracted\\20241112_Isofol_Delarsrapport_Q3_2024_Final\\20241112_Isofol_Delarsrapport_Q3_2024_Final.txt", "text_chars": 40325, "metadata": { "page_count": 17, "empty_pages": 0, "encrypted": true }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2024-q3\\extracted\\20241112_Isofol_Delarsrapport_Q3_2024_Final\\20241112_Isofol_Delarsrapport_Q3_2024_Final.extraction.json" } }, { "label": "20241112_Isofol_PM_Delarsrapport Q3 2024_Final.pdf", "url": "https://attachment.news.eu.nasdaq.com/af39229ead7b19a49fb069a48338e3967", "final_url": "https://attachment.news.eu.nasdaq.com/af39229ead7b19a49fb069a48338e3967", "filename": "20241112_Isofol_PM_Delarsrapport_Q3_2024_Final.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2024-q3\\20241112_Isofol_PM_Delarsrapport_Q3_2024_Final.pdf", "content_type": "application/pdf", "size": 114794, "sha256": "f701a0127d5467abc10b78470d9cce4f32ae4a449140b1da9ceb53489927791e", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2024-q3\\20241112_Isofol_PM_Delarsrapport_Q3_2024_Final.pdf", "filename": "20241112_Isofol_PM_Delarsrapport_Q3_2024_Final.pdf", "extension": ".pdf", "size": 114794, "sha256": "f701a0127d5467abc10b78470d9cce4f32ae4a449140b1da9ceb53489927791e", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2024-q3\\extracted\\20241112_Isofol_PM_Delarsrapport_Q3_2024_Fina\\20241112_Isofol_PM_Delarsrapport_Q3_2024_Final.txt", "text_chars": 4170, "metadata": { "page_count": 2, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2024-q3\\extracted\\20241112_Isofol_PM_Delarsrapport_Q3_2024_Fina\\20241112_Isofol_PM_Delarsrapport_Q3_2024_Final.extraction.json" } } ], "announcement_id": "1327205", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-04-fresh-local-files-v5.0.2", "retrieved_at": "2026-08-07T04:30:17Z", "company": "Isofol Medical AB", "title": "Isofol Medical AB (publ) publicerar halvårsrapport, januari - juni 2024", "category": "Halvårsrapport", "date": "2024-08-21", "language": "sv", "report_type": "interim-report", "fiscal_year": 2024, "quarter": "q2", "period": "2024-q2", "report_key": "2024:q2", "release_url": "https://view.news.eu.nasdaq.com/view?id=b1ee0bc43915515d943d87dd42b03feb9&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2024-q2\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2024-q2\\release.txt", "attachments": [ { "label": "20240821_Isofol Halvarsrapport Q2 2024_Final.pdf", "url": "https://attachment.news.eu.nasdaq.com/a7d48a6679628680da42340de12ba69d7", "final_url": "https://attachment.news.eu.nasdaq.com/a7d48a6679628680da42340de12ba69d7", "filename": "20240821_Isofol_Halvarsrapport_Q2_2024_Final.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2024-q2\\20240821_Isofol_Halvarsrapport_Q2_2024_Final.pdf", "content_type": "application/pdf", "size": 579873, "sha256": "c940e5a941818b110d8ccd64b5a29da94883b6130020954dce84b423fc63c5cf", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2024-q2\\20240821_Isofol_Halvarsrapport_Q2_2024_Final.pdf", "filename": "20240821_Isofol_Halvarsrapport_Q2_2024_Final.pdf", "extension": ".pdf", "size": 579873, "sha256": "c940e5a941818b110d8ccd64b5a29da94883b6130020954dce84b423fc63c5cf", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2024-q2\\extracted\\20240821_Isofol_Halvarsrapport_Q2_2024_Final\\20240821_Isofol_Halvarsrapport_Q2_2024_Final.txt", "text_chars": 37391, "metadata": { "page_count": 16, "empty_pages": 0, "encrypted": true }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2024-q2\\extracted\\20240821_Isofol_Halvarsrapport_Q2_2024_Final\\20240821_Isofol_Halvarsrapport_Q2_2024_Final.extraction.json" } }, { "label": "20240821_PM_Isofol_Halvarsrapport Q2 2024_Final.pdf", "url": "https://attachment.news.eu.nasdaq.com/a0041453d17c672c651c615d93b9155f1", "final_url": "https://attachment.news.eu.nasdaq.com/a0041453d17c672c651c615d93b9155f1", "filename": "20240821_PM_Isofol_Halvarsrapport_Q2_2024_Final.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2024-q2\\20240821_PM_Isofol_Halvarsrapport_Q2_2024_Final.pdf", "content_type": "application/pdf", "size": 115050, "sha256": "51b4482547c1ea193acdaf0212f80402dae5ab76df356b45903bbc3a7333da26", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2024-q2\\20240821_PM_Isofol_Halvarsrapport_Q2_2024_Final.pdf", "filename": "20240821_PM_Isofol_Halvarsrapport_Q2_2024_Final.pdf", "extension": ".pdf", "size": 115050, "sha256": "51b4482547c1ea193acdaf0212f80402dae5ab76df356b45903bbc3a7333da26", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2024-q2\\extracted\\20240821_PM_Isofol_Halvarsrapport_Q2_2024_Fin\\20240821_PM_Isofol_Halvarsrapport_Q2_2024_Final.txt", "text_chars": 4302, "metadata": { "page_count": 2, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2024-q2\\extracted\\20240821_PM_Isofol_Halvarsrapport_Q2_2024_Fin\\20240821_PM_Isofol_Halvarsrapport_Q2_2024_Final.extraction.json" } } ], "announcement_id": "1311891", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-04-fresh-local-files-v5.0.2", "retrieved_at": "2026-08-07T04:30:34Z", "company": "Isofol Medical AB", "title": "Isofol Medical AB (publ) publicerar delårsrapport, januari - mars 2024", "category": "Interimsrapport", "date": "2024-05-08", "language": "sv", "report_type": "interim-report", "fiscal_year": 2024, "quarter": "q1", "period": "2024-q1", "report_key": "2024:q1", "release_url": "https://view.news.eu.nasdaq.com/view?id=bf9432577248fe06f48f9fe5b9614d490&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2024-q1\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2024-q1\\release.txt", "attachments": [ { "label": "20240508 Isofol Delarsrapport Q1 2024 Final.pdf", "url": "https://attachment.news.eu.nasdaq.com/af85082cf68e17b2feb31a3a697929511", "final_url": "https://attachment.news.eu.nasdaq.com/af85082cf68e17b2feb31a3a697929511", "filename": "20240508_Isofol_Delarsrapport_Q1_2024_Final.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2024-q1\\20240508_Isofol_Delarsrapport_Q1_2024_Final.pdf", "content_type": "application/pdf", "size": 691953, "sha256": "bfdda2573b40bfb0b225aa2c112c05c96e0a19fdc8bd7db148383f6050795c0e", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2024-q1\\20240508_Isofol_Delarsrapport_Q1_2024_Final.pdf", "filename": "20240508_Isofol_Delarsrapport_Q1_2024_Final.pdf", "extension": ".pdf", "size": 691953, "sha256": "bfdda2573b40bfb0b225aa2c112c05c96e0a19fdc8bd7db148383f6050795c0e", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2024-q1\\extracted\\20240508_Isofol_Delarsrapport_Q1_2024_Final\\20240508_Isofol_Delarsrapport_Q1_2024_Final.txt", "text_chars": 33336, "metadata": { "page_count": 16, "empty_pages": 0, "encrypted": true }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2024-q1\\extracted\\20240508_Isofol_Delarsrapport_Q1_2024_Final\\20240508_Isofol_Delarsrapport_Q1_2024_Final.extraction.json" } }, { "label": "20240508 PM Isofol Delarsrapport Q1 2024 Final.pdf", "url": "https://attachment.news.eu.nasdaq.com/ab2ac328b1565b0aa2062d77cc448f984", "final_url": "https://attachment.news.eu.nasdaq.com/ab2ac328b1565b0aa2062d77cc448f984", "filename": "20240508_PM_Isofol_Delarsrapport_Q1_2024_Final.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2024-q1\\20240508_PM_Isofol_Delarsrapport_Q1_2024_Final.pdf", "content_type": "application/pdf", "size": 113853, "sha256": "5e8e928de713bd2f25418cf9490b9187419d0961e8eda59054b2e9e133d6f574", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2024-q1\\20240508_PM_Isofol_Delarsrapport_Q1_2024_Final.pdf", "filename": "20240508_PM_Isofol_Delarsrapport_Q1_2024_Final.pdf", "extension": ".pdf", "size": 113853, "sha256": "5e8e928de713bd2f25418cf9490b9187419d0961e8eda59054b2e9e133d6f574", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2024-q1\\extracted\\20240508_PM_Isofol_Delarsrapport_Q1_2024_Fina\\20240508_PM_Isofol_Delarsrapport_Q1_2024_Final.txt", "text_chars": 4070, "metadata": { "page_count": 2, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2024-q1\\extracted\\20240508_PM_Isofol_Delarsrapport_Q1_2024_Fina\\20240508_PM_Isofol_Delarsrapport_Q1_2024_Final.extraction.json" } }, { "label": "20240508 PM Isofol Delarsrapport Q1 2024 ISO 421 Final.pdf", "url": "https://attachment.news.eu.nasdaq.com/a5589d401e64263e071aa08abadccbaef", "final_url": "https://attachment.news.eu.nasdaq.com/a5589d401e64263e071aa08abadccbaef", "filename": "20240508_PM_Isofol_Delarsrapport_Q1_2024_ISO_421_Final.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2024-q1\\20240508_PM_Isofol_Delarsrapport_Q1_2024_ISO_421_Final.pdf", "content_type": "application/pdf", "size": 113853, "sha256": "5e8e928de713bd2f25418cf9490b9187419d0961e8eda59054b2e9e133d6f574", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2024-q1\\20240508_PM_Isofol_Delarsrapport_Q1_2024_ISO_421_Final.pdf", "filename": "20240508_PM_Isofol_Delarsrapport_Q1_2024_ISO_421_Final.pdf", "extension": ".pdf", "size": 113853, "sha256": "5e8e928de713bd2f25418cf9490b9187419d0961e8eda59054b2e9e133d6f574", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2024-q1\\extracted\\20240508_PM_Isofol_Delarsrapport_Q1_2024_ISO_\\20240508_PM_Isofol_Delarsrapport_Q1_2024_ISO_421_F.txt", "text_chars": 4070, "metadata": { "page_count": 2, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2024-q1\\extracted\\20240508_PM_Isofol_Delarsrapport_Q1_2024_ISO_\\20240508_PM_Isofol_Delarsrapport_Q1_2024_ISO_421_F.extraction.json" } } ], "announcement_id": "1294322", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-04-fresh-local-files-v5.0.2", "retrieved_at": "2026-08-07T04:30:47Z", "company": "Isofol Medical AB", "title": "Isofol Medical AB (publ) offentliggör årsredovisning och bolagsstyrningsrapport för 2023", "category": "Bokslut och Verksamhetsberättelse", "date": "2024-04-16", "language": "sv", "report_type": "annual-report", "fiscal_year": 2023, "quarter": "annual", "period": "2023-annual", "report_key": "2023:annual", "release_url": "https://view.news.eu.nasdaq.com/view?id=baed8d8983d3af33a8397b6b7d06ec34f&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2023-annual\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2023-annual\\release.txt", "attachments": [ { "label": "Isofol_Arsredovisning 2023_final.pdf", "url": "https://attachment.news.eu.nasdaq.com/aa820e256acac7ccab25d41c37090757d", "final_url": "https://attachment.news.eu.nasdaq.com/aa820e256acac7ccab25d41c37090757d", "filename": "Isofol_Arsredovisning_2023_final.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2023-annual\\Isofol_Arsredovisning_2023_final.pdf", "content_type": "application/pdf", "size": 1932726, "sha256": "621cd17ddbea35b77a8fefc759e64201c1378cd4f97ae69af188625f52803fb7", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2023-annual\\Isofol_Arsredovisning_2023_final.pdf", "filename": "Isofol_Arsredovisning_2023_final.pdf", "extension": ".pdf", "size": 1932726, "sha256": "621cd17ddbea35b77a8fefc759e64201c1378cd4f97ae69af188625f52803fb7", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2023-annual\\extracted\\Isofol_Arsredovisning_2023_final\\Isofol_Arsredovisning_2023_final.txt", "text_chars": 186610, "metadata": { "page_count": 56, "empty_pages": 0, "encrypted": true }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2023-annual\\extracted\\Isofol_Arsredovisning_2023_final\\Isofol_Arsredovisning_2023_final.extraction.json" } }, { "label": "20240416_Isofol_PM_Arsredovisning 2023_final.pdf", "url": "https://attachment.news.eu.nasdaq.com/adcdc9e1968a0d29ee3e84a8cf05df649", "final_url": "https://attachment.news.eu.nasdaq.com/adcdc9e1968a0d29ee3e84a8cf05df649", "filename": "20240416_Isofol_PM_Arsredovisning_2023_final.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2023-annual\\20240416_Isofol_PM_Arsredovisning_2023_final.pdf", "content_type": "application/pdf", "size": 60576, "sha256": "49cedb5055d4c5e70cb952ee272703d1ebb522a739bdfb138de8581e4f79b8c3", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2023-annual\\20240416_Isofol_PM_Arsredovisning_2023_final.pdf", "filename": "20240416_Isofol_PM_Arsredovisning_2023_final.pdf", "extension": ".pdf", "size": 60576, "sha256": "49cedb5055d4c5e70cb952ee272703d1ebb522a739bdfb138de8581e4f79b8c3", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2023-annual\\extracted\\20240416_Isofol_PM_Arsredovisning_2023_final\\20240416_Isofol_PM_Arsredovisning_2023_final.txt", "text_chars": 1751, "metadata": { "page_count": 1, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2023-annual\\extracted\\20240416_Isofol_PM_Arsredovisning_2023_final\\20240416_Isofol_PM_Arsredovisning_2023_final.extraction.json" } } ], "announcement_id": "1288268", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-04-fresh-local-files-v5.0.2", "retrieved_at": "2026-08-07T04:30:58Z", "company": "Isofol Medical AB", "title": "Isofol Medical AB (publ) publicerar bokslutskommuniké, januari - december 2023", "category": "Bokslutskommuniké", "date": "2024-02-20", "language": "sv", "report_type": "year-end-report", "fiscal_year": 2023, "quarter": "q4", "period": "2023-q4", "report_key": "2023:q4", "release_url": "https://view.news.eu.nasdaq.com/view?id=bdcca71bdc78ab8214e4b87fbf6949936&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2023-q4\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2023-q4\\release.txt", "attachments": [ { "label": "20240220_PM_Isofol_Bokslutskommunike_2023_ISO-402_final.pdf", "url": "https://attachment.news.eu.nasdaq.com/a5caf352b7fa2dc651bccf13f42006a1f", "final_url": "https://attachment.news.eu.nasdaq.com/a5caf352b7fa2dc651bccf13f42006a1f", "filename": "20240220_PM_Isofol_Bokslutskommunike_2023_ISO-402_final.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2023-q4\\20240220_PM_Isofol_Bokslutskommunike_2023_ISO-402_final.pdf", "content_type": "application/pdf", "size": 115217, "sha256": "dc016519f1e6c3de8a6c444c5b1964c6d43e7a0383ed0cdf4a0b1ba7d828101d", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2023-q4\\20240220_PM_Isofol_Bokslutskommunike_2023_ISO-402_final.pdf", "filename": "20240220_PM_Isofol_Bokslutskommunike_2023_ISO-402_final.pdf", "extension": ".pdf", "size": 115217, "sha256": "dc016519f1e6c3de8a6c444c5b1964c6d43e7a0383ed0cdf4a0b1ba7d828101d", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2023-q4\\extracted\\20240220_PM_Isofol_Bokslutskommunike_2023_ISO\\20240220_PM_Isofol_Bokslutskommunike_2023_ISO-402_.txt", "text_chars": 4376, "metadata": { "page_count": 2, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2023-q4\\extracted\\20240220_PM_Isofol_Bokslutskommunike_2023_ISO\\20240220_PM_Isofol_Bokslutskommunike_2023_ISO-402_.extraction.json" } }, { "label": "02191521.pdf", "url": "https://attachment.news.eu.nasdaq.com/a7602ef9b2b257549a8fe1bd4fe653349", "final_url": "https://attachment.news.eu.nasdaq.com/a7602ef9b2b257549a8fe1bd4fe653349", "filename": "02191521.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2023-q4\\02191521.pdf", "content_type": "application/pdf", "size": 505912, "sha256": "581a8e083b965bd9df8697fb5b1f1c9473150ca029bbf9f537e828bdf91f5191", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2023-q4\\02191521.pdf", "filename": "02191521.pdf", "extension": ".pdf", "size": 505912, "sha256": "581a8e083b965bd9df8697fb5b1f1c9473150ca029bbf9f537e828bdf91f5191", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2023-q4\\extracted\\02191521\\02191521.txt", "text_chars": 39153, "metadata": { "page_count": 17, "empty_pages": 0, "encrypted": true }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2023-q4\\extracted\\02191521\\02191521.extraction.json" } } ], "announcement_id": "1276022", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-04-fresh-local-files-v5.0.2", "retrieved_at": "2026-08-07T04:31:09Z", "company": "Isofol Medical AB", "title": "Isofol Medical AB (publ) publicerar delårsrapport, januari-september 2023", "category": "Interimsrapport", "date": "2023-11-10", "language": "sv", "report_type": "interim-report", "fiscal_year": 2023, "quarter": "q3", "period": "2023-q3", "report_key": "2023:q3", "release_url": "https://view.news.eu.nasdaq.com/view?id=b43e48f4a0b8b3b0dd647378a5116ddd1&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2023-q3\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2023-q3\\release.txt", "attachments": [ { "label": "20231110_PM_Isofol_Delarsrapport_Q3_2023_ISO-378_final.pdf", "url": "https://attachment.news.eu.nasdaq.com/a8683bb33855c5ca59e18514e6fa27e9e", "final_url": "https://attachment.news.eu.nasdaq.com/a8683bb33855c5ca59e18514e6fa27e9e", "filename": "20231110_PM_Isofol_Delarsrapport_Q3_2023_ISO-378_final.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2023-q3\\20231110_PM_Isofol_Delarsrapport_Q3_2023_ISO-378_final.pdf", "content_type": "application/pdf", "size": 91055, "sha256": "0d880114977069d6b61b1317e28046422e2b176068f77c59e98b5162ebd12e65", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2023-q3\\20231110_PM_Isofol_Delarsrapport_Q3_2023_ISO-378_final.pdf", "filename": "20231110_PM_Isofol_Delarsrapport_Q3_2023_ISO-378_final.pdf", "extension": ".pdf", "size": 91055, "sha256": "0d880114977069d6b61b1317e28046422e2b176068f77c59e98b5162ebd12e65", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2023-q3\\extracted\\20231110_PM_Isofol_Delarsrapport_Q3_2023_ISO-\\20231110_PM_Isofol_Delarsrapport_Q3_2023_ISO-378_f.txt", "text_chars": 3756, "metadata": { "page_count": 2, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2023-q3\\extracted\\20231110_PM_Isofol_Delarsrapport_Q3_2023_ISO-\\20231110_PM_Isofol_Delarsrapport_Q3_2023_ISO-378_f.extraction.json" } }, { "label": "11092219.pdf", "url": "https://attachment.news.eu.nasdaq.com/a1aebb2df992cfd76ff2c5291a77df6c8", "final_url": "https://attachment.news.eu.nasdaq.com/a1aebb2df992cfd76ff2c5291a77df6c8", "filename": "11092219.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2023-q3\\11092219.pdf", "content_type": "application/pdf", "size": 546624, "sha256": "5f5a0f6ce2caf510301dd75dcdedd98b8b59b786c1ecbaa64b194f3c234530a6", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2023-q3\\11092219.pdf", "filename": "11092219.pdf", "extension": ".pdf", "size": 546624, "sha256": "5f5a0f6ce2caf510301dd75dcdedd98b8b59b786c1ecbaa64b194f3c234530a6", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2023-q3\\extracted\\11092219\\11092219.txt", "text_chars": 48615, "metadata": { "page_count": 21, "empty_pages": 0, "encrypted": true }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2023-q3\\extracted\\11092219\\11092219.extraction.json" } } ], "announcement_id": "1258528", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-04-fresh-local-files-v5.0.2", "retrieved_at": "2026-08-07T04:31:18Z", "company": "Isofol Medical AB", "title": "Isofol Medical AB (publ) publicerar halvårsrapport, januari-juni 2023", "category": "Halvårsrapport", "date": "2023-08-22", "language": "sv", "report_type": "interim-report", "fiscal_year": 2023, "quarter": "q2", "period": "2023-q2", "report_key": "2023:q2", "release_url": "https://view.news.eu.nasdaq.com/view?id=b74d12a04055165f4cf583d3335fa8462&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2023-q2\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2023-q2\\release.txt", "attachments": [ { "label": "20230822_Isofol_Halvarsrapport Q2 2023_ISO-372_final.pdf", "url": "https://attachment.news.eu.nasdaq.com/a9e9f689ce594cebf31181362f4489de2", "final_url": "https://attachment.news.eu.nasdaq.com/a9e9f689ce594cebf31181362f4489de2", "filename": "20230822_Isofol_Halvarsrapport_Q2_2023_ISO-372_final.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2023-q2\\20230822_Isofol_Halvarsrapport_Q2_2023_ISO-372_final.pdf", "content_type": "application/pdf", "size": 530976, "sha256": "dfc41859f861523d002b9d4fc5bbfa568547f4828e8ee60412b2670d8292398d", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2023-q2\\20230822_Isofol_Halvarsrapport_Q2_2023_ISO-372_final.pdf", "filename": "20230822_Isofol_Halvarsrapport_Q2_2023_ISO-372_final.pdf", "extension": ".pdf", "size": 530976, "sha256": "dfc41859f861523d002b9d4fc5bbfa568547f4828e8ee60412b2670d8292398d", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2023-q2\\extracted\\20230822_Isofol_Halvarsrapport_Q2_2023_ISO-37\\20230822_Isofol_Halvarsrapport_Q2_2023_ISO-372_fin.txt", "text_chars": 48576, "metadata": { "page_count": 20, "empty_pages": 0, "encrypted": true }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2023-q2\\extracted\\20230822_Isofol_Halvarsrapport_Q2_2023_ISO-37\\20230822_Isofol_Halvarsrapport_Q2_2023_ISO-372_fin.extraction.json" } }, { "label": "08219168.pdf", "url": "https://attachment.news.eu.nasdaq.com/a4f4c8326235e26886d600a7b74d68e2b", "final_url": "https://attachment.news.eu.nasdaq.com/a4f4c8326235e26886d600a7b74d68e2b", "filename": "08219168.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2023-q2\\08219168.pdf", "content_type": "application/pdf", "size": 107482, "sha256": "0ffad7b4d38388c17c9ca6b1e3501dba25bec7a69fc6493981b8eb9254895173", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2023-q2\\08219168.pdf", "filename": "08219168.pdf", "extension": ".pdf", "size": 107482, "sha256": "0ffad7b4d38388c17c9ca6b1e3501dba25bec7a69fc6493981b8eb9254895173", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2023-q2\\extracted\\08219168\\08219168.txt", "text_chars": 3784, "metadata": { "page_count": 2, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2023-q2\\extracted\\08219168\\08219168.extraction.json" } } ], "announcement_id": "1243665", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-04-fresh-local-files-v5.0.2", "retrieved_at": "2026-08-07T04:31:29Z", "company": "Isofol Medical AB", "title": "Isofol Medical AB (publ) publicerar delårsrapport, januari-mars 2023", "category": "Interimsrapport", "date": "2023-05-03", "language": "sv", "report_type": "interim-report", "fiscal_year": 2023, "quarter": "q1", "period": "2023-q1", "report_key": "2023:q1", "release_url": "https://view.news.eu.nasdaq.com/view?id=bb514f30c1fbf5b05cd70b4c6704281f9&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2023-q1\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2023-q1\\release.txt", "attachments": [ { "label": "05020206.pdf", "url": "https://attachment.news.eu.nasdaq.com/a48653f20d1db5a6ba15b7f0c7b4d17e2", "final_url": "https://attachment.news.eu.nasdaq.com/a48653f20d1db5a6ba15b7f0c7b4d17e2", "filename": "05020206.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2023-q1\\05020206.pdf", "content_type": "application/pdf", "size": 112134, "sha256": "1bddf33fcb179495d348e85d8dd56f6d815504b9335a38c4cf2c7efbe6e155cd", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2023-q1\\05020206.pdf", "filename": "05020206.pdf", "extension": ".pdf", "size": 112134, "sha256": "1bddf33fcb179495d348e85d8dd56f6d815504b9335a38c4cf2c7efbe6e155cd", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2023-q1\\extracted\\05020206\\05020206.txt", "text_chars": 4568, "metadata": { "page_count": 2, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2023-q1\\extracted\\05020206\\05020206.extraction.json" } }, { "label": "20230503_Isofol_Delarsrapport Q1 2023_ISO-345_final.pdf", "url": "https://attachment.news.eu.nasdaq.com/acccded929db5e3f2c6b18045e5036e33", "final_url": "https://attachment.news.eu.nasdaq.com/acccded929db5e3f2c6b18045e5036e33", "filename": "20230503_Isofol_Delarsrapport_Q1_2023_ISO-345_final.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2023-q1\\20230503_Isofol_Delarsrapport_Q1_2023_ISO-345_final.pdf", "content_type": "application/pdf", "size": 521879, "sha256": "e3d6476b33400d7e168c5e7e0964756cc0dc5a1b2ae984a1afc9267d0f4cabfe", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2023-q1\\20230503_Isofol_Delarsrapport_Q1_2023_ISO-345_final.pdf", "filename": "20230503_Isofol_Delarsrapport_Q1_2023_ISO-345_final.pdf", "extension": ".pdf", "size": 521879, "sha256": "e3d6476b33400d7e168c5e7e0964756cc0dc5a1b2ae984a1afc9267d0f4cabfe", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2023-q1\\extracted\\20230503_Isofol_Delarsrapport_Q1_2023_ISO-345\\20230503_Isofol_Delarsrapport_Q1_2023_ISO-345_fina.txt", "text_chars": 43718, "metadata": { "page_count": 19, "empty_pages": 0, "encrypted": true }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\isofol-medical\\nasdaq-reports\\reports\\2023-q1\\extracted\\20230503_Isofol_Delarsrapport_Q1_2023_ISO-345\\20230503_Isofol_Delarsrapport_Q1_2023_ISO-345_fina.extraction.json" } } ], "announcement_id": "1224821", "status": "retrieved" } ], "attempts": [ { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Isofol+Medical&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "sv", "start": 0, "pagination": "row-offset", "query_text": "Isofol Medical", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "4d5de818f25c7331a2e0caf0a8156cd62d60f73a0d66f42f3cadb202d7ee4f02" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Isofol+Medical&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=100&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "sv", "start": 100, "pagination": "row-offset", "query_text": "Isofol Medical", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "eddab476195f8a48c01e4cf544961b59443f8ab04e031278170c6f8a41216e8c" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Isofol+Medical&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=200&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "sv", "start": 200, "pagination": "row-offset", "query_text": "Isofol Medical", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 34, "new_rows": 34, "total_count": null, "from_cache": false, "body_sha256": "f4d9f43faf85fb92b1efdab592ab2fc1edfd1475e6e149516a0b0211658c7a8d" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Isofol+Medical&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=234&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "sv", "start": 234, "pagination": "row-offset", "query_text": "Isofol Medical", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 0, "new_rows": 0, "total_count": null, "from_cache": false, "body_sha256": "40db23ea0e848f3c1212b154bafe97e61b6e5a2ac9f8c5df69fab8eccd853f28" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Isofol+Medical&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicFirstNorth&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC", "status": 200, "scope": "NordicFirstNorth", "language": "sv", "start": 0, "pagination": "row-offset", "query_text": "Isofol Medical", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 2, "new_rows": 2, "total_count": null, "from_cache": false, "body_sha256": "495cc731e926e1151dbde1404bb03f92ed66db72f93354fa4bdd75df2f4bd266" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Isofol+Medical&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicFirstNorth&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=2&dir=DESC", "status": 200, "scope": "NordicFirstNorth", "language": "sv", "start": 2, "pagination": "row-offset", "query_text": "Isofol Medical", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 0, "new_rows": 0, "total_count": null, "from_cache": false, "body_sha256": "8cf81a327a3a8b325adfd784ef5b23173c052fd172113cb13a000ad4e443c411" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Isofol+Medical&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "en", "start": 0, "pagination": "row-offset", "query_text": "Isofol Medical", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "d225f85d0002ede0dfa8fac60395ac76b9a910365e66bc297bb276febe90af9e" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Isofol+Medical&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=100&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "en", "start": 100, "pagination": "row-offset", "query_text": "Isofol Medical", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 84, "new_rows": 84, "total_count": null, "from_cache": false, "body_sha256": "d7c658c0a3f01978ceec1c232211498094ac9cdc3914200b6c312a5c921bc9f6" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Isofol+Medical&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=184&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "en", "start": 184, "pagination": "row-offset", "query_text": "Isofol Medical", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 0, "new_rows": 0, "total_count": null, "from_cache": false, "body_sha256": "bbf212a9405568e16e58fc0d4da512e30df886864a4d6b2a82e007ffa927c5d1" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Isofol+Medical&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicFirstNorth&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC", "status": 200, "scope": "NordicFirstNorth", "language": "en", "start": 0, "pagination": "row-offset", "query_text": "Isofol Medical", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 1, "new_rows": 1, "total_count": null, "from_cache": false, "body_sha256": "d187f99d16b56dc81c37f45e80c13f308dd13df057d580e570b8de9abcda9507" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Isofol+Medical&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicFirstNorth&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=1&dir=DESC", "status": 200, "scope": "NordicFirstNorth", "language": "en", "start": 1, "pagination": "row-offset", "query_text": "Isofol Medical", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 0, "new_rows": 0, "total_count": null, "from_cache": false, "body_sha256": "b0baeec2e2e08d034f3e6378faf59c9d544cb3d1cd4e64d2dae5360d27808f71" } ], "identity": { "slug": "", "instrument_id": "TX2339902", "resolved_url": "https://www.nasdaq.com/european-market-activity/shares/isofol?id=TX2339902" }, "transport": "ordinary-http", "browser_used": false, "query_text": "Isofol Medical", "retrieved_at": "2026-08-07T04:31:29Z" }